Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Birgit WEHNL"'
Autor:
Thomas Muley, Xiaotong Zhang, Stefan Holdenrieder, Catharina M Korse, Xiu-yi Zhi, Rafael Molina, Zhongjuan Liu, Gunther Hartmann, Michel M van den Heuvel, Kun Qian, Ramon Marrades, Christine Engel, Ying He, Birgit Wehnl, Farshid Dayyani, Felix Herth
Publikováno v:
Tumor Biology, Vol 42 (2020)
This study aimed to investigate whether changes in progastrin-releasing peptide (ProGRP) levels correlate with treatment response and can be used to optimize clinical management of patients with small-cell lung cancer. Patients with small-cell lung c
Externí odkaz:
https://doaj.org/article/de453d033ca24de7ad50985f43964c44
Autor:
Catharina M. KORSE, Stefan HOLDENRIEDER, Xiuyi ZHI, Xiaotong ZAHNG, Ling QIU, Andrea GEISTANGER, Marcus-Rene LISY, Birgit WEHNL, Daan van den BROEK, José M. ESCUDERO, Jens STANDOP, Mu HU, Rafael MOLINA
Publikováno v:
Chinese Journal of Lung Cancer, Vol 20, Iss 8, Pp 568-577 (2017)
Externí odkaz:
https://doaj.org/article/5d8df451677041339a69b03a224dee64
Autor:
Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A. Schneider, Felix J. Herth, Birgit Wehnl, Maximilian Diehn, Ash A. Alizadeh, John F. Palma, Thomas Muley
Publikováno v:
Cancers; Volume 14; Issue 10; Pages: 2479
Monitoring treatment efficacy early during therapy could enable a change in treatment to improve patient outcomes. We report an early assessment of response to treatment in advanced NSCLC using a plasma-only strategy to measure changes in ctDNA level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06111e2a114669f3f6e8adf330042682
https://pubmed.ncbi.nlm.nih.gov/35626082
https://pubmed.ncbi.nlm.nih.gov/35626082
Autor:
Stefan Holdenrieder, Mark Kriegsmann, R. Gerber, Michael Meister, Vinzent Rolny, Birgit Wehnl, Fjf Herth, Marc A. Schneider, A. Mang, Michael Thomas, Thomas Muley, C.P. Heussel
Publikováno v:
Journal of Thoracic Oncology. 16:S1028-S1029
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86a165fdeeff3aebd7dd4b0d44336739
https://doi.org/10.1016/j.jtho.2021.08.364
https://doi.org/10.1016/j.jtho.2021.08.364
Autor:
Wei Zou, Mark A. Socinski, D. Morgenstern, David S. Shames, Katja Schulze, Birgit Wehnl, A. Mazumder, Martin Reck, D. Cigoianu, Vinzent Rolny, Namrata Patil, A. Mang
Publikováno v:
Journal of Thoracic Oncology. 16:S1024-S1025
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77ec5dd3f5f3468f7fbf736917f2af65
https://doi.org/10.1016/j.jtho.2021.08.356
https://doi.org/10.1016/j.jtho.2021.08.356
Autor:
Michel M van den Heuvel, Ramon M. Marrades, Rafael Molina, Stefan Holdenrieder, Christine Engel, Birgit Wehnl, Catharina M. Korse, Xiuyi Zhi, Felix J.F. Herth, Ying He, Kun Qian, Thomas Muley, Farshid Dayyani, Xiaotong Zhang, Zhongjuan Liu, Gunther Hartmann
Publikováno v:
Tumor Biology, 42, 9
Tumor Biology, Vol 42 (2020)
Tumor Biology, 42
Tumor Biology, Vol 42 (2020)
Tumor Biology, 42
Contains fulltext : 225028.pdf (Publisher’s version ) (Open Access) This study aimed to investigate whether changes in progastrin-releasing peptide (ProGRP) levels correlate with treatment response and can be used to optimize clinical management of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a234c13b0c9acdadf0350a0e4605c5d8
https://hdl.handle.net/2066/225028
https://hdl.handle.net/2066/225028
Autor:
Marc A. Schneider, Arne Warth, Christa Stolp, Michael Meister, Ying He, Farshid Dayyani, Hendrik Dienemann, Vinzent Rolny, Birgit Wehnl, Achim Escherich, Felix J.F. Herth, Thomas Muley
Publikováno v:
Lung Cancer. 120:46-53
Objectives To determine whether the tumor biomarkers cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA), which are prognostic in early-stage non-small cell lung cancer (NSCLC), can predict which patients benefit from adjuvant che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc728eaceaf0a6aa7a207939c76e6b5
https://doi.org/10.1016/j.lungcan.2018.03.015
https://doi.org/10.1016/j.lungcan.2018.03.015
Autor:
Karina Hettwer, Kirsten Simon, Farshid Dayyani, Stefan Holdenrieder, Steffen Uhlig, Birgit Wehnl
Publikováno v:
British journal of cancer, vol 116, iss 8
British Journal of Cancer
British Journal of Cancer
Background: This meta-analysis evaluated whether pretherapy serum levels of carcinoembryonic antigen (CEA) and cytokeratin-19 fragments (CYFRA 21-1) are predictive of response to therapy in non-small cell lung cancer (NSCLC) and whether changes in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244ba7682b4628c011ea48e9a087ab18
https://doi.org/10.1038/bjc.2017.45
https://doi.org/10.1038/bjc.2017.45
Autor:
C.P. Heussel, B. Hinzmann, Michael Meister, Fjf Herth, Corinna Woestmann, Mark Kriegsmann, Birgit Wehnl, Michael Thomas, Marc A Schneider, John F. Palma, Stephanie J. Yaung, T Muley, John Jiang, Christine Ju
Publikováno v:
Annals of Oncology. 31:S1041-S1042
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b74a1693983709cbbb7c9a8d63423474
https://doi.org/10.1016/j.annonc.2020.08.1561
https://doi.org/10.1016/j.annonc.2020.08.1561
Autor:
Marc A. Schneider, Michael Meister, Thomas Muley, Achim Escherich, Felix J.F. Herth, Farshid Dayyani, Christa Stolp, Birgit Wehnl, Arne Warth, Vinzent Rolny, Ying He
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 130
Objectives The biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymis protein 4 (HE4) are useful in the diagnosis, prognosis, and monitoring of non-small cell lung cancer (NSCLC), but their combination has not been investigated yet. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76836838e3f29983cf968fa7d4531ed
https://pubmed.ncbi.nlm.nih.gov/30885344
https://pubmed.ncbi.nlm.nih.gov/30885344